Skip to content

Industry verticals

Warm Introductions in Healthcare IT and Digital Health Sales

Hospital CIOs and CMIOs are among the most cold-outreach-immune buyers in B2B: every unvetted vendor triggers a compliance review before a conversation begins. Three structural introduction channels that pre-empt that screening: the CHIME CIO peer community, the AVIA Digital Health cooperative, and the Epic and Oracle Health EHR ecosystems.

Why cold outreach fails in health system technology sales

Hospital CIOs and Chief Medical Information Officers (CMIOs) operate under a distinctive dual pressure that makes them among the most cold-outreach-immune buyers in B2B. On the clinical side, adopting an unvetted technology platform creates patient safety risk: a flawed clinical decision support tool or care coordination platform can directly harm patients, and no CIO accepts that liability from an unknown vendor. On the compliance side, every new vendor that handles patient data triggers a HIPAA Business Associate Agreement, a vendor security assessment, and often a clinical informatics committee review. The combination means that a cold email from a digital health company lands in the same mental category as a compliance risk notification: something to be screened out, not evaluated. The result is that health system technology procurement is almost entirely relationship-mediated before a formal evaluation begins. Gartner data on health system IT procurement shows that major platform decisions (EHR integrations, RCM systems, clinical AI platforms) take 12 to 24 months from initial awareness to contract, and the initial awareness almost always comes through a trusted peer channel: a CIO colleague who adopted the technology, a health system innovation network that pre-evaluated it, or an existing technology partner who introduced it. Vendors who reach evaluation through these channels spend months doing product work; vendors who enter through cold outreach spend those months establishing basic credibility.

Three structural mechanics for reaching health system buyers

Health system technology sales has three primary warm introduction channels, each addressing a different trust barrier in a different part of the procurement cycle.

The CHIME community: CIO peer introductions

CHIME, the College of Healthcare Information Management Executives, is the professional organization that concentrates health IT leadership from hospital systems, integrated delivery networks (IDNs), physician groups, and long-term care organizations. The CHIME Fall Forum and CHIME25 conference bring together more than 5,000 health IT leaders annually; the CHIME Most Wired benchmarking program is the primary survey through which health system CIOs share technology adoption data with peers. Within this community, vendor evaluation conversations happen as a professional norm. A CIO evaluating a new digital health platform will contact two or three peer CIOs at comparable health systems before committing to an evaluation. This is so standard that CHIME has built peer connection programs (CHIME Advisory Groups, CHIME CIO Community Calls) specifically to facilitate it. A vendor whose technology has been adopted by a CHIME board member or committee chair arrives with a peer endorsement that pre-empts the initial compliance and clinical risk screening that every unknown vendor triggers. The Granovetter bridge-position mechanism applies directly here: a CHIME committee chair who serves on the Precision Medicine and Genomics working group holds bridging relationships with CIOs across dozens of health systems simultaneously, and their endorsement of a specific genomics analytics vendor carries more informational weight than any vendor marketing because it reflects operational experience across multiple implementation contexts. Building a CHIME advisory relationship requires sustained engagement: participation in working groups and presentation of real implementation data at CHIME sessions, not a single conference badge scan.

AVIA Digital Health: structured vendor evaluation by member health systems

AVIA is the leading digital health cooperative, a membership organization that includes over 50 health system members (including Kaiser Permanente, Ascension, Providence, Intermountain Health, UCHealth, and UCSF Health) who collectively use the network to identify and evaluate digital health vendors on shared priority use cases. AVIA's model is structurally different from a traditional accelerator or investor program: member health systems define their operational and clinical priorities (reducing ED readmissions, improving care coordination for chronic conditions, reducing prior authorization burden), AVIA identifies vendors addressing those priorities across its network, and then facilitates structured evaluation by multiple member health systems simultaneously. A vendor admitted to AVIA's evaluation process arrives at member health systems as a pre-evaluated solution for a specific use case, with AVIA's multi-system assessment substituting for each health system's independent vendor due diligence. The Doney and Cannon trust mechanism applied to AVIA's institutional structure creates a portfolio endorsement dynamic: when Intermountain Health adopts a care coordination platform through an AVIA evaluation, Providence and UCHealth, who participated in the same evaluation, carry a reference implementation from a peer system they trust. The introduction is not from the vendor but from the cooperative evaluation itself, which is why AVIA adoption carries more purchase-decision weight than a single reference customer call.

Epic App Orchard and Oracle Health Marketplace: EHR ecosystem introductions

Epic and Oracle Health (Cerner) together serve the majority of US hospital systems above 200 beds. This market concentration creates an EHR ecosystem dynamic: a digital health application that does not integrate with the health system's EHR platform is practically unevaluable, because clinical workflow tools that can't read and write patient data from the EHR require duplicate data entry and create reconciliation risk. Epic's App Orchard and Oracle Health's Marketplace formalize this integration requirement as a vendor credentialing mechanism. A vendor listed in the App Orchard has completed Epic's technical review process, including an assessment of FHIR API compliance, data security standards, and workflow integration points. When a health system CIO asks Epic's account team about complementary digital health tools for a specific use case, such as prior authorization automation, ambient clinical documentation, or patient-reported outcomes collection, the Epic account team refers them to App Orchard-listed vendors who have already completed the technical integration prerequisite. The Schmitt and Van den Bulte trust-transfer mechanism explains why this works: Epic's institutional authority with its 350+ hospital system customer base means that Epic's implicit technical endorsement (through App Orchard listing) propagates across every Epic-installed health system simultaneously. A vendor who invests in App Orchard certification gains a structural introduction channel to the entire Epic-installed base, not through cold outreach but through the EHR platform's existing trust relationship with each health system's CIO. The same logic applies to Oracle Health's Marketplace for the Cerner-installed health systems.

The CMIO and clinical informatics committee: the clinical champion path

Most health system technology decisions involve two distinct approval tracks running in parallel. The CIO and IT governance committee evaluate the technical architecture, security posture, and integration complexity. The CMIO and clinical informatics committee evaluate clinical validity: does the technology improve patient outcomes, and does the clinical workflow it creates impose burden on physicians without commensurate benefit? For clinical decision support tools, AI diagnostic assistants, and care coordination platforms that touch physician workflows, the CMIO approval is often the harder gate. CMIOs are practicing physicians who evaluate technology against their clinical judgment, and a vendor whose technology has been validated in a peer-reviewed study presented by a physician champion at a CMIO peer community (AMIA, HIMSS Clinical & Business Intelligence, physician specialty society conferences) carries clinical credibility that vendor marketing cannot manufacture. HIMSS (Healthcare Information and Management Systems Society) is the other major conference community for health IT professionals: the HIMSS Annual Conference draws 35,000+ attendees across CIOs, CMIOs, nursing informatics leads, and health IT vendors. Participation in HIMSS Innovation Programming and the HIMSS Davies Award process (recognizing health systems achieving measurable health outcomes through health IT) creates the professional community relationships that produce CMIO-to-CMIO peer introductions for clinical technology adoption.

Buyer facts: who evaluates and what they need

Health system technology procurement involves a broader committee than most B2B contexts. The CIO leads IT governance and vendor evaluation on technical and security dimensions. The CMIO leads clinical technology evaluation and physician adoption considerations. Clinical informatics directors and VP-level IT infrastructure leaders manage implementation risk. The CFO and revenue cycle leadership evaluate financial impact and ROI. And nursing informatics and department medical directors evaluate workflow fit for frontline staff. Key timing dynamics: major platform evaluations (EHR integrations, RCM systems) require 12–24 months from initial awareness to contract signature. Smaller clinical tools with defined use cases may move in 6–12 months. Fiscal year budget cycles (typically July–June or January–December depending on the health system) create defined windows for new vendor commitments: late Q3 and early Q4 of the fiscal year are when evaluations that might proceed to contract next fiscal year need to be in active evaluation. KLAS Research is the primary independent analyst firm that health system CIOs use to evaluate vendor performance across clinical categories. A strong KLAS score functions as a third-party peer endorsement. KLAS scores are built entirely from health system client interviews, so a positive KLAS rating means peer health systems have validated vendor performance in production environments, which is the most credible signal available to a CIO evaluating an unfamiliar vendor.

FAQ

Healthcare IT Sales FAQs

How is healthcare IT sales different from medtech or pharma sales?

Healthcare IT sells software platforms and data tools to hospital CIOs, CMIOs, and IT governance committees: the buyer is a technology executive evaluating integration complexity, security architecture, and workflow impact. Medtech sells physical devices (surgical instruments, monitoring equipment, diagnostic hardware) to clinical champions (surgeons, cardiologists, radiologists) with GPO and IDN procurement. Pharma sells approved drugs to physician prescribers through KOL and Medical Science Liaison relationships under strict Sunshine Act compliance. The buyers, connector layers, evaluation criteria, and compliance frameworks are entirely different across all three.

What is CHIME and why does it matter for healthcare IT sales?

CHIME is the College of Healthcare Information Management Executives, the professional organization for health IT leaders (CIOs, CMIOs, CTOs) at hospital systems, IDNs, and physician groups. The CHIME Fall Forum and CHIME25 are the primary peer conferences where CIOs share technology evaluation experiences. Sustained participation (presenting implementation data at CHIME sessions, joining working groups, building relationships with CHIME board members) creates the peer advisory relationships that translate into warm introduction access to health system CIOs you have not met.

How does Epic App Orchard work as a vendor introduction channel?

Epic's App Orchard is a marketplace of third-party applications that have completed Epic's technical integration review process, confirming FHIR API compatibility, data security compliance, and workflow integration capability. When a health system CIO or CMIO asks their Epic account team about tools for a specific use case (prior authorization, ambient documentation, care gaps), the account team refers to App Orchard-listed vendors. The listing functions as a structural introduction channel to Epic's 350+ hospital system customers, not through cold outreach but through Epic's existing trust relationship with each health system.

What role does AVIA Digital Health play for digital health vendors?

AVIA is a health system digital health cooperative: its 50+ member health systems (including Kaiser, Ascension, Providence, Intermountain) define their operational priorities, AVIA identifies vendors addressing those priorities, and multiple member health systems evaluate vendors simultaneously through AVIA's structured process. An AVIA Select designation means your technology has been evaluated by multiple major health systems as addressing a validated clinical or operational priority, which substitutes for independent vendor due diligence at each member health system and functions as a portfolio introduction to the entire member network.

How long does health system IT procurement typically take?

Gartner and KLAS data consistently show 12–24 months for major platform decisions (EHR integrations, RCM systems, clinical AI platforms). Smaller point solutions with well-defined clinical use cases may progress in 6–12 months. Fiscal year budget cycles and IT governance committee calendars create defined evaluation windows: a vendor not in evaluation before Q3 of a health system's fiscal year typically will not receive a budget commitment until the next fiscal cycle. KLAS scores and AVIA membership accelerate the early stages by substituting for independent due diligence.

Is HIMSS worth the investment for a digital health vendor?

HIMSS Annual Conference draws 35,000+ health IT professionals and is where CIOs, CMIOs, and clinical informatics leaders evaluate market landscape in a concentrated way. For a vendor establishing initial credibility, HIMSS booth presence is less valuable than HIMSS Innovation Programming participation (which creates structured engagement with health system evaluators) or presenting data at a HIMSS Clinical & Business Intelligence session (which builds CMIO peer credibility). The HIMSS Digital Health Innovation Summit specifically targets hospital system innovation leaders. Targeted involvement in specific HIMSS working groups is more valuable than general booth presence.

Keep reading

Fundamentals

What is a warm introduction?

Comparison

Warm introductions vs. cold outreach

B2B sales

Why cold outreach stops working

Get warm introductions to health system decision-makers

LetsBridge helps you map who in your network can introduce you to hospital CIOs, CMIOs, and health system innovation teams, and guides them through making a compelling introduction.

See how it worksFor companies